Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cogent Biosciences Inc
COGTCurrent price
10.47 USD
-0.82 USD (-7.26%)
Last closed
11.24 USD
Company
www.cogentbio.com
ISIN
US19240Q2012
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 175 492 992 USD
Yield for 12 month
-14.67 %
1Y
3Y
5Y
10Y
15Y
COGT
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Address: 275 Wyman Street, Waltham, MA, United States, 02451
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
16.1 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-3 588 000 USD
Last Year
-5 878 000 USD
Current Quarter
-1 080 000 USD
Last Quarter
-1 066 000 USD
Key Figures COGT
1 year
3 years
5 years
10 years
EBITDA
-242 215 008 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-37.18 %
PEG Ratio
–
Return On Equity TTM
-62.92 %
Wall Street Target Price
16.1 USD
Revenue TTM
–
Book Value
2.37 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
-121 627 000 USD
Earnings per share
-2.49 USD
Diluted Eps TTM
-2.49 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics COGT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History COGT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:4
Payout Ratio
–
Last Split Date
09.11.2020
Dividend Date
09.11.2020
Stock Valuation COGT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
925.407
Price Sales TTM
1320.6301
Enterprise Value EBITDA
-3.8852
Price Book MRQ
4.541
Financials COGT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators COGT
For 52 weeks
3.67 USD
13.23 USD
50 Day MA
9.16 USD
Shares Short Prior Month
10 106 416
200 Day MA
7.36 USD
Short Ratio
16.2
Shares Short
10 230 915
Short Percent
10.35 %
BeatStart